By Caroline Pailliez and Lea Guedj
PARIS, March 8 (Reuters) – Parisian resident Nadine Roger, 60, recovering from breast cancer, is at high risk of COVID-19 and wants to be vaccinated as quickly as possible. However, when offered the vaccine manufactured by AstraZeneca, she refused it.
“The AstraZeneca (shooting) scares me,” she said. Roger, a medical technician, said she would instead wait for the shot from U.S. firm Johnson & Johnson, which has yet to be approved by European regulators.
According to the most recent data made available by the Ministry of Health, France was using 24% of its doses of AstraZeneca by the end of February, against 82% for the vaccines manufactured by Pfizer / BioNTech and 37% for the Moderna vaccine.
This is in part due to logistical bottlenecks, but also to the fact that some French people do not trust the AstraZeneca vaccine – despite multiple scientific studies indicating that it is safe and effective – according to interviews conducted by Reuters with eight people involved in the deployment of the vaccine in France.
They said some of those who received the vaccine were worried about side effects, skeptical of its effectiveness against newer variants of COVID-19 and confused by …
Read Additional From Source
Copyright @ finance.yahoo.com
News Highlights Science
- According to the source Science says it’s safe, but some in France don’t trust AstraZeneca vaccine
- Check all news and articles from the Science news information updates.